Citations

Clear

72 citation(s) found for "Lucas, John".

Reliability of remote self‐administered Web‐based digital cognitive measures and comparison to in‐person neuropsychological tests: Stricker Learning Span, Symbols Test, and the Mayo Test Drive Screening Battery Composite
Hughes, Morgan A., Frank, Ryan D. , Taylor, Rita L. , Fan, Winnie Z. , Christianson, Teresa J., Kremers, Walter K. , Stricker, John L. , Lucas, John A. , Aduen, Paula, Graff‐Radford, Neill R., Graff-Radford, Jonathan, Petersen, Ronald C., Aduen, Paula A., Kremers, Walter K , Hughes, Morgan A., Machulda, Mary M. , Hassenstab, Jason , Mielke, Michelle M. , Day, Gregory S. , Graff‐Radford, Neill R. , Jack, Clifford R. , Graff‐Radford, Jonathan , Petersen, Ronald C. , Stricker, Nikki H.

Mayo Clinic

Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring | May 11, 2026 | Volume: 18 | Issue: 2 | Pages: No page available

10.1002/dad2.70338 | PMID 42125541 Get It

Abstract INTRODUCTION We describe the reliability of remote self‐administered digital cognitive measures completed via the Mayo Test Drive (MTD) web‐based platform. METHODS A total of 1846 participants (mean age = 70, SD = 12, range 31–101; 48% male; 96% White; 99% non‐Hispanic; 97% cognitively unimpaired) with two to four complete MTD sessions at ∼7.5‐month intervals were included. Test‐retest reliability was assessed using single‐rating, absolute‐agreement, and two‐way mixed intraclass correlation coefficients (ICCs) with 95% confidence intervals. ICCs for in‐person‐administered traditional neuropsychological measures were compared to MTD for a subset of 244 participants. Analyses also compared reliability across demographic, residential, and session context subgroups. RESULTS Reliability was good for the MTD Composite (total ICC = 0.79 [0.77, 0.80]), and moderate‐to‐good for the primary outcome variables for each MTD subtest (total ICCs 0.70–0.83 for Stricker Learning Span and Symbols). The reliability of the remote self‐administered MTD was similar to in‐person‐administered cognitive measures. DISCUSSION MTD showed moderate‐to‐good reliability, supporting its use in longitudinal monitoring.
The 20‐item Noise Pareidolia Task: normative data and performance in MCI‐LB and DLB
Lucas, John A., Aakre, Jeremiah A. , Graff‐Radford, Neill R., Knopman, David S., Graff‐Radford, Jonathan, Fields, Julie A. , Aduen, Paula, Machulda, Mary M., Savica, Rodolfo, Lachner, Christian, Day, Gregory S., Miyagawa, Toji , Petersen, Ronald C., Kantarci, Kejal, Boeve, Bradley F., Day, Gregory S. , Day, Gregory S , Ferman, Tanis J. , Lucas, John A. , Nishio, Yoshiyuki , Graff‐Radford, Neill R. , Knopman, David S. , Graff‐Radford, Jonathan , Machulda, Mary M. , Savica, Rodolfo , Lachner, Christian , McCarter, Stuart J. , Petersen, Ronald C. , Kantarci, Kejal , Boeve, Bradley F. , Aduen, Paula A.

Mayo Clinic

Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring | March 30, 2026 | Volume: 18 | Issue: 2 | Pages: No page available

10.1002/dad2.70312 | PMID 42866414 Get It

Abstract INTRODUCTION Visual perceptual difficulties occur in dementia with Lewy bodies (DLB). Normative data and cut scores for DLB and mild cognitive impairment with Lewy bodies (MCI‐LB) are needed for the 20‐item Noise Pareidolia Task. METHODS Participants included 344 cognitively unimpaired (CU), 112 DLB, and 105 MCI‐LB. Cumulative percentile ranking was used for normative classification. Receiver operating characteristic analyses, convergent validity, and associations with visual hallucinations (VH) were assessed. RESULTS In CU participants, a perfect score was average, one error was low average, and two or more errors fell below average. A cut score of one or more errors optimally distinguished CU participants from DLB (Total score area under the curve [AUC]: 0.82, Noise score AUC: 0.77) and MCI‐LB (Total score AUC: 0.75, Noise score AUC: 0.74). A cut score of two or more errors lowered sensitivity but increased specificity to 94%. Performance was associated with VH in DLB, but not MCI‐LB. DISCUSSION Results establish normative data for the 20‐item Noise Pareidolia Task and support its use in DLB and MCI‐LB.
Prognostic role of PET / CT volumetric parameters in paediatric Hodgkin lymphoma: A systematic review and expert recommendations from the International
Gowdy, S. Claire , Flerlage, Jamie E. , Palese, Monica , Castellino, Sharon M., Cho, Steve , Dieckmann, Karin, Hoppe, Bradford S. , Howard, Scott, Kelly, Kara M., Kurch, Lars , Lai, Hollie , Lopci, Egesta, Lucas, John T., Mauz‐Körholz, Christine, McCarten, Kathleen M. , Pandit‐Taskar, Neeta, Steglich, Jonas , Stoevesandt, Dietrich, Voss, Stephan D. , Milgrom, Sarah A. , Lucas, John T. , Gowdy, Claire , Hoppe, Bradford S , Stoevesandt, Dietrich , Flerlage, Jamie E , Seelisch, Jennifer , Bradshaw, Tyler , Castellino, Sharon M. , Dieckmann, Karin, Kelly, Kara M. , Lucas, John T., Mauz‐Körholz, Christine , Pandit-Taskar, Neeta D. , Schöder, Heiko

Mayo Clinic

British Journal of Haematology | January 15, 2026 | Volume: 208 | Issue: 4 | Pages: 1185-1195

10.1111/bjh.70329 | PMID 41535222 Get It

Summary In adults with classic Hodgkin lymphoma (cHL), metabolic tumour volume (MTV) is valuable for risk stratification. This systematic review explored the role of volumetric parameters in children, adolescents and young adults (CAYA) with cHL. This systematic review was performed according to the Preferred Reporting Items for Systematic Reviews and Meta‐Analyses (PRISMA) method. Five databases were searched on 16 October 2024. Eligible studies were peer‐reviewed manuscripts, written in English, published since database inception that included patients ≤21 years of age with a diagnosis of cHL treated with chemotherapy ± radiotherapy with a baseline 18 F‐Fluorodeoxyglucose (F‐FDG) PET/CT scan for MTV quantification. The search strategy identified 3669 studies, of which 35 were eligible for inclusion. Fifteen studies (43%) evaluated a cohort exclusively ≤21 years of age. All eight studies that explored the association of baseline PET parameters with known risk factors identified a significant correlation. Nine of 12 papers (75%) demonstrated a statistically significant correlation with disease response to therapy on PET/CT. Fifteen of 20 papers (75%) demonstrated an independent statistically significant correlation with clinical outcomes. In the CAYAHL population, volumetric PET parameters are valuable for risk stratification despite heterogeneity in results. Future harmonization of the segmentation approach will facilitate incorporation of MTV into clinical practice.
Drivers of Below‐Cutoff Scores on Bedside Cognitive Screening in Cognitively Normal Ethnoracially Diverse Adults
Aduen, Paula, Lucas, John A., Lachner, Christian, Piura, Yoav , Schecter, Leah, Carrasquillo, Minerva M., White, Richard O. , Graff‐Radford, Neill R., Day, Gregory S, Jain, Manoj , Lucas, John A. , Lachner, Christian , Carrasquillo, Minerva M. , Graff‐Radford, Neill R. , Day, Gregory S.

Mayo Clinic

Alzheimer's & Dementia | December 26, 2025 | Volume: 21 | Issue: S3 | Pages: No page available

10.1002/alz70857_105661 Get It

Abstract Background Bedside cognitive screening tools intend to reliably and efficiently detect cognitive impairment in research, clinical, and community settings. Black American (BA) and Hispanic/Latino (H/L) adults obtain lower performance on widely used screeners, largely driven by demographics and structural and social determinants of health (SSDoH). This study characterized the performance of the Montreal Cognitive Assessment (MoCA) performance in a cohort of cognitively normal ethnoracially diverse adults while considering cohort‐specific factors that contributed to misclassification of impairment. Method Cognitively normal BA and H/L participants completed a comprehensive neurological assessment, neuropsychological testing, and MRI and amyloid‐ and tau‐PET imaging as part of a longitudinal study of memory and aging at Mayo Clinic in Florida. Demographically adjusted MoCA cutoffs were applied to BA (MoCA ≤ 22) and WH/L (MoCA ≤ 24) subgroups. Hierarchical binary logistic regression assessed whether amyloid burden (Centiloid value) improved prediction of scoring below demographically adjusted MoCA cutoffs beyond demographic/SSDoH factors, including age, education, and Area Deprivation Index (ADI). Result Participants included 105 (47 WH/L, 58 BA/AA) cognitively normal adults (mean age = 64.71 years, SD = 8.91; 62.9% female) with average of 16.07 years of education (SD=2.35) and mild‐to‐moderate neighborhood disadvantage (mean ADI=47.60, SD=23.77). 40% of H/L participants (MoCA (≤ 24) and 17% of BA participants (MoCa ≤22) scored below demographically adjusted MoCA cut‐offs. For the H/L subgroup, the best fitting model included age, education, ADI, and amyloid burden ( R 2 = 0 .43, χ 2 = 10.98, p = 0.03). Age (OR=1.21, 95% CI: 0.986 – 1.487) and amyloid burden (OR = 0.83, 95% CI: 0.67 – 1.03) approached statistical significance as individual predictors ( p = 0.06, p = 0.09). In the BA/AA subgroup, the best fitting model included age, education and ADI only ( R 2 = 0.47, χ 2 = 9.06, p = 0.02), with education approaching significance as an individual predictor (OR=0.46, 95% CI: 0.21 – 1.01, p = 0.05). Conclusion Sociodemographic factors continued to drive low MoCA performance in cognitively normal individuals despite applying demographically adjusted cut‐off scores by subgroup. These factors differentially impacted performance among BA/AA and WH/L participants. Careful consideration of these factors is warranted to mitigate risk of overdiagnosing impairment based on cognitive screening across clinical and research settings.
Targeted plasma eQTL and pQTL analyses to identify potential novel biomarkers for Alzheimer's Disease in African Americans
Badillo, Vanessa M. Colon, Reddy, Joseph S. , Jin, Jiangli , Lincoln, Sarah, Ho, Charlotte C.G. , Wang, Xue, Malphrus, Kimberly G., Nguyen, Thuy T., Polanco, Jean M Marrero, Tamvaka, Nicole , Lachner, Christian, Day, Gregory S, Lucas, John A., Graff‐Radford, Neill R., Ertekin‐Taner, Nilüfer, Carrasquillo, Minerva M., Crook, Julia E. , Wang, Xue, Nguyen, Thuy T. , Kuchenbecker, Lindsey A. , Marrero‐Polanco, Jean , Lachner, Christian , Day, Gregory S. , Lucas, John A. , Graff‐Radford, Neill R. , Ertekin‐Taner, Nilüfer , Carrasquillo, Minerva M.

Mayo Clinic

Alzheimer's & Dementia | December 26, 2025 | Volume: 21 | Issue: S2 | Pages: No page available

10.1002/alz70856_104423 Get It

Abstract Background African Americans (AA) are twice as likely to develop dementia than non‐Hispanic Whites but remain underrepresented in Alzheimer's Disease (AD) research. Recent studies have identified AA specific risk factors for AD. Therefore, targeted biomarkers and/or therapies may be needed to effectively treat AD in AA. In this study, we aimed to determine if genetic variants that show association with AD‐risk, plasma transcript or protein levels in AA, may serve as accurate and accessible AD biomarkers. Method In 189 clinically diagnosed AA AD cases and 183 AA cognitively unimpaired (CU) controls, we performed targeted DNA sequencing of 10 AD‐associated loci. Genetic variants at these loci were tested for association with corresponding plasma transcripts and total tau protein levels previously measured in this cohort using a custom nanoString panel and Simoa assays, respectively. Utilizing phased haplotypes (SHAPEIT4) from target sequencing, we inferred local ancestry (RFMix v2) using five superpopulations from the 1000 Genomes Project as anchors. Subsequently, we tested the association of each ancestry specific allelic dosages with endophenotypes using Tractor. In receiver operating characteristic (ROC) analyses, the most significant e/pQTLs were added sequentially to a base model that included age and sex to identify e/pQTLs that improved the accuracy to correctly classify AD cases and CU controls. Result Of the 5,112 variants that were tested, 70 were nominally associated with AD‐risk and with plasma transcript or protein levels. Seven of these 70 variants also showed nominally significant associations of AD‐risk and transcript levels with either African or East Asian local ancestry. ROC analysis of age, sex, 33 e/pQTLs in APOE , SORL1 , TLR4 , EPHA1 , ABCA7 , CLU , and CR1 , and plasma levels of APP, ABCA7, AKAP9, CD14, CLU, and APOE ‐ɛ4 dosage achieved 88.2% area under the curve to discriminate AD vs. CU, a 30.4% improvement over the base model that only included age and sex. Conclusion Plasma transcript levels and e/pQTLs are promising diagnostic biomarkers for AD that may improve accessibility and reduce costs for a more accurate diagnosis of AD.
Novel set of plasma proteins classifies Alzheimer's dementia in African Americans with high accuracy
Hurst, Cheyenne , Huang, Yen‐Ning, Opdenbosch, Bianca M., Reddy, Joseph S. , Nguyen, Thuy T., Casellas, Heidi L., Sotelo, Katie D., Reddy, Delila J., Tsai, Wei, Lucas, John A. , Day, Gregory S, Willis, Floyd B. , Ramanan, Vijay K., Graff‐Radford, Neill R., Ertekin‐Taner, Nilüfer, Nho, Kwangsik, Carrasquillo, Minerva M., Kuchenbecker, Lindsey A. , Thompson, Kevin J. , Huang, Yen-Ning , Heckman, Michael G. , Nguyen, Thuy T. , Sotelo, Katie D., Day, Gregory S. , Ramanan, Vijay K. , Graff‐Radford, Neill R. , Ertekin‐Taner, Nilüfer , Nho, Kwangsik T. , Kalari, Krishna R. , Carrasquillo, Minerva M.

Mayo Clinic

Alzheimer's & Dementia | December 25, 2025 | Volume: 21 | Issue: S2 | Pages: No page available

10.1002/alz70856_100297 Get It

Abstract Background Plasma biomarkers offer improved accessibility compared to established diagnostic modalities for Alzheimer's disease (AD). However, current plasma biomarker candidates have not been tested comprehensively in diverse populations, and represent only a fraction of pathways dysregulated in AD. This study seeks to address these knowledge gaps through untargeted plasma biomarker discovery in African Americans (AA), an underrepresented group in AD research despite having a higher risk of developing dementia compared to non‐Hispanic Whites (NHW). Method Untargeted proteomics were generated using the SomaScan 7k platform on plasma samples from AA study participants clinically diagnosed as AD dementia ( n = 181) or cognitively unimpaired (CU; n = 142). Machine learning was implemented to identify a set of plasma proteins to distinguish between AD dementia and CU. Predictive models were constructed by elastic net regression optimized with nested cross‐validation on 6,853 proteins and evaluated by receiver operating characteristic analysis. The generalizability of plasma protein predictors was evaluated in an external Alzheimer's Disease Research Center cohort of 369 NHW and AA study participants diagnosed as AD dementia or CU. Result Thirty‐six proteins were selected as predictors. Proteins selected by machine learning were enriched for processes previously associated with AD including synaptic dysfunction, inflammation, vascular dysfunction, and amyloid processing. The 36 plasma proteins alone achieved an area under the curve (AUC) of 0.94 to classify AD dementia in the discovery cohort, representing a 22% improvement over a model including age and sex. The 36 proteins were validated in an external cohort also achieving AUC=0.94, a 35% improvement over age and sex. Conclusion Biomarker discovery combining untargeted proteomics and machine learning identified a set of plasma proteins that could serve as a novel and highly accurate diagnostic plasma biomarker panel for AD. Work is underway to assess the association of the predictive panel with p ‐tau217, medical comorbidities, and social/structural determinants of health.
Mayo Normative Studies: a conditional normative model for longitudinal change in performance on remote digital cognitive measures including the Stricker Learning Span, Symbols Test and Mayo Test Drive Screening Battery Composite
Frank, Ryan D. , Christianson, Teresa J., Fan, Winnie Z. , Hughes, Morgan A, Stricker, John L. , Machulda, Mary M., Lucas, John A. , Hassenstab, Jason J., Aduen, Paula, Day, Gregory S, Graff‐Radford, Neill R., Jack, Clifford R., Graff‐Radford, Jonathan, Petersen, R. C., Hughes, Morgan A , Kremers, Walter K. , Machulda, Mary M. , Hassenstab, Jason , Day, Gregory S. , Graff‐Radford, Neill R. , Jack, Clifford R. , Graff‐Radford, Jonathan , Petersen, Ronald, Stricker, Nikki H.

Mayo Clinic

Alzheimer's & Dementia | December 25, 2025 | Volume: 21 | Issue: S3 | Pages: No page available

10.1002/alz70857_099872 Get It

Abstract Background Self‐administered and remote digital cognitive assessments provide a scalable method for screening and longitudinal cognitive monitoring. Mayo Test Drive (MTD) is one such assessment with previously demonstrated usability, reliability, validity and multi‐device compatibility. MTD includes a computer‐adaptive word list memory test (Stricker Learning Span) and a measure of processing speed/executive functioning (Symbols Test) that combine to provide an MTD Composite. This study aimed to develop a conditional normative model predicting longitudinal cognitive change for MTD, and to validate the model in two independent samples of cognitively unimpaired (CU) and mild cognitive impairment (MCI)/dementia (DEM) participants. Method 1355 CU participants at initial MTD assessment with 2‐4 consecutive MTD assessments every 7.5 months comprised the development dataset. Linear mixed effects models were used to construct a conditional normative model for MTD assessments 2‐4. The baseline model was chosen a priori , consisting of age, sex, education, baseline score, number of assessments, and time. Device type, race, and baseline score by time interactions were also considered. Variables were only added if a >1% increment in r‐squared was observed. The models were externally validated in 113 CU and 51 MCI/DEM patients. Following model development, the data were updated and additional follow‐up MTD assessments were added for many participants, including the addition of additional CU validation data at test 3 ( N = 126) and 4 ( N = 279). T‐tests compared observed and predicted differences and residual z‐scores between development and validation at each follow‐up assessment. Result Table 1 presents demographic variables. No additional variables increased the r‐squared by >1%. The final models are presented in Table 2. Age, baseline score, sex, and education were significant. Residual z‐scores were not significantly different between CU development and CU validation cohorts, indicating observed scores were in line with model predicted scores. Residual z‐scores were significantly worse among MCI/DEM compared to CU development in 11/12 comparisons (Figure 1), indicating observed scores were below model predicted expectations and implying sensitivity to longitudinal cognitive decline. Conclusion These longitudinal normative models can be used to identify individuals with follow‐up scores outside of expected predicted ranges, signifying abnormal longitudinal cognitive decline.
Socioeconomic deprivation and medical comorbidity burden associations with clinicopathologic characteristics in an ethnoracially diverse Alzheimer's disease autopsy series
Lachner, Christian, Emrani, Sheina , Dunlop, Sara , Rawlinson, Bailey, Engelberg‐Cook, Erica, Ventura, Josalen, Velez‐Uribe, Idaly, Graff‐Radford, Neill R., Day, Gregory S, Lucas, John A. , Murray, Melissa E., Lachner, Christian , Kuchenbecker, Lindsey A. , Engelberg-Cook, Erica , Vélez-Uribe, Idaly , Peng, Zhongwei , Haydu, Lauren E. , Dickson, Dennis W. , Graff‐Radford, Neill R. , Day, Gregory S. , Murray, Melissa E.

Mayo Clinic

Alzheimer's & Dementia | December 25, 2025 | Volume: 21 | Issue: S1 | Pages: No page available

10.1002/alz70855_107360 Get It

Abstract Background Population aging is expected to increase the burden of Alzheimer's disease (AD) and related dementias (ADRD), yet up to 45% of ADRD risk may be modified. Disparities in ADRD burden among Hispanic/Latino and Black/African Americans suggests that socioeconomic deprivation and medical comorbidities may influence AD risk. The relationship between these factors, symptomatic age of onset, and neuropathologic findings in AD remains unclear. This study aims to investigate these associations in an ethnoracially diverse, neuropathologically diagnosed AD case series. Understanding these risk factors may help develop more effective AD risk reduction strategies. Method We queried the Florida Autopsied Multi‐Ethnic (FLAME) cohort database for neuropathologically‐diagnosed AD cases with available age onset of cognitive symptoms, who self‐identified as Hispanic/Latino ( n = 75) or Black/African American ( n = 22). Cases were matched to non‐Hispanic White decedents ( n = 101) by sex and year of birth. Medical records at the time of brain donation were retrospectively reviewed, assessing completeness for demographics, clinical characteristics, and medical comorbidities (Table 1). Result The table shows a comparative analysis stratified by young‐onset AD (YOAD, onset <65 years) and late‐onset AD (LOAD, onset ≥65 years). YOAD cases had a significantly higher level of education compared to LOAD ( p = 0.003). No differences were observed in sex , APOE ε4 carriership, or Area Deprivation Index between YOAD and LOAD. However, YOAD cases had a longer disease duration and were more likely to present with atypical clinical features compared to LOAD (both p <0.001). YOAD cases also showed a faster rate of decline on MMSE compared to LOAD ( p = 0.002), higher frequency of depression ( p = 0.018), and lower frequency of stroke/TIA ( p = 0.025). YOAD cases also had lower brain weight ( p = 0.041), less cerebrovascular disease burden ( p = 0.003) and higher neurofibrillary tangle density in association cortices ( p <0.001) compared to LOAD cases. Conclusion Socioeconomic deprivation and most medical comorbidities were not associated with AD symptomatic onset. Despite having higher education levels and lower cerebrovascular burden, YOAD decedents experienced faster cognitive decline but a longer disease course, with more frequent atypical clinical presentations and depression compared to LOAD. Further discussion will address the topographic distribution of tangle and plaque pathology.
Prognostic value of 18F-FDG PET/CT volumetric parameters in childhood, adolescent, and young adult Hodgkin lymphoma (CAYAHL): a systematic review from the international SEARCH group (Staging, Evaluation and Response Criteria Harmonization)
Castellino, S, Dieckmann, Karin, Kelly, Kara M. , Kurch, Lars , Lai, Hollie , Mauz-Koerholz, Christine, McCarten, Kathleen M. , Steglich, J., Stoevesandt, Dietrich, Voss, Stephan D. , Milgrom, Sarah A. , Gowdy, Claire , Flerlage, Jamie E. , Seelisch, Jennifer , Palese, M, Bradshaw, Tyler , Castellino, Sharon M. , Cho, Steve K. , Hoppe, Bradford S. , Howard, Scott C. , Lopci, Egesta , Lucas, John T. , Mauz‐Körholz, Christine , Pandit-Taskar, Neeta D. , Schöder, Heiko

Mayo Clinic

Klinische Pädiatrie | December 3, 2025 | Volume: 237 | Issue: No issue available | Pages: No page available

10.1055/s-0045-1812922 Get It